In a preclinical study on mice bearing established subcutaneous B16 melanoma, the interaction of CD134 on NK cells with CD134L present on dendritic cells resulted in the release of IFN-γ and induced T cell cross-priming against multiple tumor antigens [95]. This evidence concerns the gene IFNG and neoplasm.